OMD has won the global business for the animal health division of Boehringer Ingelheim. The billings are estimated to be between USD$90 million to USD$100 million and Zenith is believed to be the incumbent.
The assignment covers Asia-Pacific, Europe, Middle East and Africa and the US – the largest market for BI accounting for 60% of billings. The remit includes cross media and channel planning and buying.
OMD’s mandate covers petcare products Frontline and NexGard.
source: http://www.mumbrella.asia
